, Tracking Stock Market Picks
Enter Symbol:
Immunomedics, Inc. (IMMU) [hlAlert]

down 51.36 %

Immunomedics, Inc. (IMMU) rated Buy with price target $6 by WallachBeth

Posted on: Monday,  Jun 3, 2013  10:25 AM ET by WallachBeth

WallachBeth rated Buy Immunomedics, Inc. (NASDAQ: IMMU) on 06/03/2013, when the stock price was $4.03. Since
then, Immunomedics, Inc. has lost 51.36% as of 01/07/2016's recent price of $1.96.
If you would have followed this WallachBeth's recommendation on IMMU, you would have lost 51.36% of your investment in 948 days.

Immunomedics Inc. is a New Jersey-based biopharmaceutical company focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases. They have developed a number of advanced proprietary technologies that allow us to create humanized antibodies that can be used either alone in unlabeled or `naked` form, or conjugated with radioactive isotopes, chemotherapeutics or toxins, in each case to create highly targeted agents. Using these technologies, the company have built a pipeline of therapeutic product candidates that utilize several different mechanisms of action. They have recently licensed its lead product candidate, epratuzumab, to UCB, S.A. for the treatment of all autoimmune disease indications worldwide.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/3/2013 10:25 AM Buy
4.03 6.00
as of 12/13/2013
1 Week down  -12.83 %
1 Month up  9.44 %
3 Months down  -34.98 %
1 YTD down  -2.23 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy